开云网页登录_开云app官网入口下载苹果版

Abstract

CLC Number:

R593.2

Figures/Tables1

References50

[1]	Duarte-García A, Fang H, To CH, et al. Seasonal variation in the activity of systemic lupus erythematosus[J]. J Rheumatol, 2012, 39(7):1392-1398. doi:10.3899/jrheum.111196pmid:22660806
[2]	Szeto CC, Mok HY, Chow KM, et al. Climatic influence on the prevalence of noncutaneous disease flare in systemic lupus erythematosus in Hong Kong[J]. J Rheumatol, 2008, 35(6):1031-1037. doi:10.1093/rheumatology/35.10.1031 URL
[3]	Meza-Meza MR, Muñoz-Valle JF, Ruiz-Ballesteros AI, et al. Association of high calcitriol serum levels and its hydroxylation efficiency ratio with disease risk in SLE patients with vitamin D deficiency[J]. J Immunol Res, 2021, 2021:2808613.
[4]	Amital H, Szekanecz Z, Szücs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?[J]. Ann Rheum Dis, 2010, 69(6):1155-1157. doi:10.1136/ard.2009.120329pmid:20439290
[5]	Robeva R, Tanev D, Kirilov G, et al. Decreased daily melatonin levels in women with systemic lupus erythematosus - a short report[J]. Balkan Med J, 2013, 30(3):273-276. doi:10.5152/balkanmedj.2013.8064 URL
[6]	Medrano-Campillo P, Sarmiento-Soto H, álvarez-Sánchez N, et al. Evaluation of the immunomodulatory effect of melatonin on the T-cell response in peripheral blood from systemic lupus erythematosus patients[J]. J Pineal Res, 2015, 58(2):219-226. doi:10.1111/jpi.12208pmid:25612066
[7]	Sanders CJ, Van Weelden H, Kazzaz GA, et al. Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol[J]. Br J Dermatol, 2003, 149(1):131-137. doi:10.1046/j.1365-2133.2003.05379.x URL
[8]	Bengtsson AA, Rylander L, Hagmar L, et al. Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden[J]. Rheumatology (Oxford), 2002, 41(5):563-571. doi:10.1093/rheumatology/41.5.563 URL
[9]	Visser E, Milne D, Collacott I, et al. The epidemiology of infectious mononucleosis in Northern Scotland: a decrea-sing incidence and winter peak[J]. BMC Infect Dis, 2014, 14:151. doi:10.1186/1471-2334-14-151 URL
[10]	Jacoby RK, Jayson MI, Cosh JA. Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up[J]. Br Med J, 1973, 2(5858):96-100.
[11]	Fleming A, Crown JM, Corbett M. Early rheumatoid di-sease. I. Onset[J]. Ann Rheum Dis, 1976, 35(4):357-360. pmid:970994
[12]	de Rooy DP, Andersson ML, Knevel R, et al. Does the season at symptom onset influence the long-term severity of radiographic joint destruction in rheumatoid arthritis?[J]. Ann Rheum Dis, 2012, 71(12):2055-2056. doi:10.1136/annrheumdis-2012-201565pmid:22764041
[13]	Iikuni N, Nakajima A, Inoue E, et al. What′s in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity[J]. Rheumatology (Oxford), 2007, 46(5):846-848. doi:10.1093/rheumatology/kel414 URL
[14]	Mori H, Sawada T, Nishiyama S, et al. Influence of seasonal changes on disease activity and distribution of affected joints in rheumatoid arthritis[J]. BMC Musculoskelet Disord, 2019, 20(1):30. doi:10.1186/s12891-019-2418-2 URL
[15]	Rozin A, Balbir-Gurman A, Schapira D. Seasonal distribution of relapse onset in rheumatoid arthritis and spondyloarthropathy: the possible effect of the solar factor[J]. Clin Exp Rheumatol, 2003, 21(2):161-169. pmid:12747269
[16]	Arkema EV, Hart JE, Bertrand KA, et al. Exposure to ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses′ Health Study[J]. Ann Rheum Dis, 2013, 72(4):506-511. doi:10.1136/annrheumdis-2012-202302 URL
[17]	McGrath H Jr, Smith JL, Bak E, et al. Ultraviolet-A light in the treatment of rheumatoid arthritis[J]. Clin Exp Rheumatol, 1987, 5(4):323-328. pmid:3440328
[18]	Fouani M, Basset CA, Mangano GD, et al. Heat shock proteins alterations in rheumatoid arthritis[J]. Int J Mol Sci, 2022, 23(5):2806. doi:10.3390/ijms23052806 URL
[19]	Huang MN, Yu H, Moudgil KD. The involvement of heat-shock proteins in the pathogenesis of autoimmune arthritis: a critical appraisal[J]. Semin Arthritis Rheum, 2010, 40(2):164-175. doi:10.1016/j.semarthrit.2009.10.002 URL
[20]	Lin J, Liu J, Davies ML, et al. Serum vitamin D level and rheumatoid arthritis disease activity: review and meta-analysis[J]. PLoS One, 2016, 11(1):e0146351. doi:10.1371/journal.pone.0146351 URL
[21]	Cutolo M, Otsa K, Laas K, et al. Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe[J]. Clin Exp Rheumatol, 2006, 24(6):702-704. pmid:17207389
[22]	Attar SM. Vitamin D deficiency in rheumatoid arthritis. Vitamin D deficiency in rheumatoid arthritis. Prevalence and association with disease activity in Western Saudi Arabia[J]. Saudi Med J, 2012, 33(5):520-525.
[23]	Kostoglou-Athanassiou I, Athanassiou P, Lyraki A, et al. Vitamin D and rheumatoid arthritis[J]. Ther Adv Endocrinol Metab, 2012, 3(6):181-187. doi:10.1177/2042018812471070 URL
[24]	Senior BW, Anderson GA, Morley KD, et al. Evidence that patients with rheumatoid arthritis have asymptomatic ′non-significant′ Proteus mirabilis bacteriuria more frequently than healthy controls[J]. J Infect, 1999, 38(2):99-106. pmid:10342649
[25]	Auger I, Roudier J. A function for the QKRAA amino acid motif: mediating binding of DnaJ to DnaK. Implications for the association of rheumatoid arthritis with HLA-DR4[J]. J Clin Invest, 1997, 99(8):1818-1822. pmid:9109425
[26]	van Setten G, Labetoulle M, Baudouin C, et al. Evidence of seasonality and effects of psychrometry in dry eye di-sease[J]. Acta Ophthalmol, 2016, 94(5):499-506. doi:10.1111/aos.12985 URL
[27]	Rantanen II, Tenovuo JO, Pienihäkkinen K, et al. Seasonal variation in dry mouth symptoms of Sjögren′s syndrome patients: a clinical follow-up study[J]. Clin Exp Rheumatol, 2003, 21(5):682. pmid:14611133
[28]	Müller K, Oxholm P, Sørensen OH, et al. Abnormal vitamin D3 metabolism in patients with primary Sjögren′s syndrome[J]. Ann Rheum Dis, 1990, 49(9):682-684. pmid:2173501
[29]	Agmon-Levin N, Kivity S, Tzioufas AG, et al. Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren′s syndrome[J]. J Autoimmun, 2012, 39(3):234-239. doi:10.1016/j.jaut.2012.05.018pmid:22835660
[30]	Erten Š, Šahin A, Altunoğlu A, et al. Comparison of plasma vitamin D levels in patients with Sjögren′s syndrome and healthy subjects[J]. Int J Rheum Dis, 2015, 18(1):70-75. doi:10.1111/1756-185X.12298 URL
[31]	Igoe A, Scofield RH. Autoimmunity and infection in Sjögren′s syndrome[J]. Curr Opin Rheumatol, 2013, 25(4):480-487. doi:10.1097/BOR.0b013e32836200d2pmid:23719365
[32]	Kivity S, Arango MT, Ehrenfeld M, et al. Infection and autoimmunity in Sjögren′s syndrome: a clinical study and comprehensive review[J]. J Autoimmun, 2014, 51:17-22. doi:10.1016/j.jaut.2014.02.008pmid:24637076
[33]	Pasoto SG, Natalino RR, Chakkour HP, et al. EBV reactivation serological profile in primary Sjögren′s syndrome: an underlying trigger of active articular involvement?[J]. Rheumatol Int, 2013, 33(5):1149-1157. doi:10.1007/s00296-012-2504-3 URL
[34]	Watson HR, Robb R, Belcher G, et al. Seasonal variation of Raynaud′s phenomenon secondary to systemic sclerosis[J]. J Rheumatol, 1999, 26(8):1734-1737. pmid:10451070
[35]	Maricq HR, Carpentier PH, Weinrich MC, et al. Geographic variation in the prevalence of Raynaud′s phenomenon: a 5 region comparison[J]. J Rheumatol, 1997, 24(5):879-889. pmid:9150076
[36]	Emmanuel G, Saroja D, Gopinathan K, et al. Environmental factors and the diffusing capacity of the lung in progressive systemic sclerosis[J]. Chest, 1976, 69(2 Suppl):304-307. pmid:1248313
[37]	Vacca A, Cormier C, Piras M, et al. Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis[J]. J Rheumatol, 2009, 36(9):1924-1929. doi:10.3899/jrheum.081287 URL
[38]	Seriolo B, Molfetta L, Cutolo M. Seasonal variations in serum levels of 25-hydroxyvitamin D in patients with systemic sclerosis[J]. Clin Rheumatol, 2011, 30(3):445-446. doi:10.1007/s10067-011-1684-7pmid:21234627
[39]	Zerr P, Vollath S, Palumbo-Zerr K, et al. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis[J]. Ann Rheum Dis, 2015, 74(3):e20. doi:10.1136/annrheumdis-2013-204378 URL
[40]	Usategui A, Criado G, Del Rey MJ, et al. Topical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma[J]. Arch Dermatol Res, 2014, 306(8):757-761. doi:10.1007/s00403-014-1466-6 URL
[41]	Kotulska A, Brzezinska-Wcislo L, Kucharz EJ. Circadian profile of serum melatonin in patients with systemic sclerosis[J]. Clin Exp Rheumatol, 2005, 23(5):728-729. pmid:16173262
[42]	Dang H, Dauphinée MJ, Talal N, et al. Serum antibody to retroviral gag proteins in systemic sclerosis[J]. Arthritis Rheum, 1991, 34(10):1336-1337. doi:10.1002/art.1780341022 URL
[43]	Neidhart M, Kuchen S, Distler O, et al. Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis[J]. Arthritis Rheum, 1999, 42(2):389-392. doi:10.1002/1529-0131(199902)42:2<389::AID-ANR23>3.0.CO;2-P URL
[44]	Åkerblom A, Helmersson-Karlqvist J, Weitoft T, et al. Seasonal variations of urate in a Swedish adult population[J]. Clin Rheumatol, 2017, 36(7):1595-1598. doi:10.1007/s10067-017-3591-zpmid:28283767
[45]	Ahn H, Lee G, Lee GS. Lower temperatures exacerbate NLRP3 inflammasome activation by promoting monoso-dium urate crystallization, causing gout[J]. Cells, 2021, 10(8):1919. doi:10.3390/cells10081919 URL
[46]	Kardeš S. Seasonal variation in the internet searches for gout: an ecological study[J]. Clin Rheumatol, 2019, 38(3):769-775. doi:10.1007/s10067-018-4345-2 URL
[47]	Sugimoto R, Watanabe H, Ikegami K, et al. Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism[J]. Kidney Int, 2017, 91(3):658-670. doi:S0085-2538(16)30597-Xpmid:27988213
[48]	Ponvilawan B, Charoenngam N, Ungprasert P. Primary hyperparathyroidism is associated with a higher level of serum uric acid: a systematic review and meta-analysis[J]. Int J Rheum Dis, 2020, 23(2):174-180. doi:10.1111/1756-185X.13740pmid:31692271
[49]	He YS, Wang GH, Wu Q, et al. The relationship between ambient air pollution and hospitalizations for gout in a humid subtropical region of china[J]. J Inflamm Res, 2021, 14:5827-5835. doi:10.2147/JIR.S329706 URL
[50]	Ryu HJ, Seo MR, Choi HJ, et al. Particulate matter (PM 10) as a newly identified environmental risk factor for acute gout flares: a time-series study[J]. Joint Bone Spine, 2021, 88(2):105108. doi:10.1016/j.jbspin.2020.105108 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables1

References50

Related Articles15

Recommended Articles

Metrics

Comments

[1]	DIAO Xuehong, SHEN Yan, CHEN Lin, ZHAN Jia, FANG Liang, CAI Jianfei, CHEN Yue.Application of superb microvascular imaging technology in diagnosing rheumatoid arthritis in the clinical remission stage[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 575-580.
[2]	.[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 299-303.
[3]	ZHANG Hao, CHI Huihui, SU Yutong, YANG Chengde.Study on advances in the association between autoantibodies and clinical phenotypes in idiopathic inflammatory myopathy[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 408-414.
[4]	LU Hongyu, GU Jun, WANG Jing, CAO Yafeng, SONG Luxi, FAN Jun, CHEN Mei.Sjögren′s syndrome secondary to cryptococcal meningoencephalitis: a case report and literature review[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(05): 456-461.
[5]	.[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(01): 8-14.
[6]	.[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(01): 98-103.
[7]	.[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 113-116.
[8]	WANG Yanqing, HUANG Wanxue, LIANG Yuanyuan, WU Zhenzhen, WANG Xuan, TANG Jianping.Clinical and laboratory analysis of primary Sjögren′s syndrome complicated with neurological lesions[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 51-55.
[9]	.[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 109-112.
[10]	.[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(05): 616-619.
[11]	.[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(05): 606-610.
[12]	YUAN Yiwei, GU Juanfang, FEI Zhangli, YANG Mingfeng, WANG Yiwen, WANG Hongzhi.Level of programmed cell death factor 5 in patients with active rheumatoid arthritis[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(04): 453-456.
[13]	.[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 244-248.
[14]	.[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 347-351.
[15]	.[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 249-253.